In conclusion, the present study suggests that pancreatic fat and liver fat measured by abdominal CT scans might be ameliorated after treatment with SGLT‐2 inhibitors in type 2 diabetes patients with intense fat depositions in these organs. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.